Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients - JAMA Network
jamanetwork.comSubmitted by jamanetworkcom5065 in news
This 32-country randomized clinical trial assesses the effects of bempedoic acid on cardiovascular outcomes in statin-intolerant patients receiving bempedoic acid vs placebo for primary prevention of a first major adverse cardiovascular event.